Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Szarek to Receptors, Urokinase Plasminogen Activator

This is a "connection" page, showing publications Michael Szarek has written about Receptors, Urokinase Plasminogen Activator.

 
Connection Strength
 
 
 
0.237
 
  1. Ismail A, Erne G, Vasbinder A, Hutten CG, Ghazzal BZ, Pizzo I, Diaz KM, Catalan TC, Farhat T, Knott B, Kunkle P, Szarek M, Davies MJ, Steg PG, Pitt B, Bhatt DL, Hayek SS. Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study. J Card Fail. 2026 Aug; 32(8):1362-1372.
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)